D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KLRS holding history
Kalaris Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KLRS overviewAll 13F holders of KLRSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −296,461−100.0% | Sold out | Holders |
| Q3 2024 | 296,461 | $239.7K | <0.1% | −179,124−37.7% | Reduced | Holders |
| Q2 2024 | 475,585 | $344.0K | <0.1% | −394,277−45.3% | Reduced | Holders |
| Q1 2024 | 869,862 | $656.7K | <0.1% | +617,223+244.3% | Added | Holders |
| Q4 2023 | 252,639 | $171.7K | <0.1% | +252,639 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −61,672−100.0% | Sold out | Holders |
| Q1 2021 | 61,672 | $1.44M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.